₨ 20,000.00
MBBS
Benepali 50mg pack of 2 Prefilled pen (Etanercept) ^
- Generic Name: Etanercept
- Manufactured by : Pfizer
- Drug Strength : 50mg
- Pack Size : 1
Etanercept contains Benepali and is now available in Pakistan. The price of Etanercept is Rs.20000 as of 1st January 2025 it can be purchased online from MedicalStore.com.pk. The prices are updated regularly on this page.
Alternate brands of Benepali 50mg pack of 2 Prefilled pen (Etanercept) ^
| Brand Name | Price | Savings |
|---|---|---|
| Enbrel 50mg (Pack of 2 Pre filled Pen) ^ | ₨ 40,000.00 | You will pay -20000 more |
| Enbrel 25mg prefilled pen (Pack of 2 pen) ^ | ₨ 30,000.00 | You will pay -10000 more |
| Enbrel Pre-fill Syringe 50 mg 4 Pre filled Syringe | ₨ 100,000.00 | You will pay -80000 more |
How it works
Benepali 50mg pack of 2 Prefilled pen (Etanercept) ^ works by blocking the action of certain specific substances in the body that causes inflammation and other associated complications.
Side effects
Major & minor side effects for Benepali 50mg pack of 2 Prefilled pen (Etanercept) ^
- Chills and fever
- Cough
- Sneezing
- Sore throat
- Itching and skin rash
- Headache
- Nausea
- Dizziness
Uses of Benepali 50mg pack of 2 Prefilled pen (Etanercept) ^
What is it prescribed for?
-
Rheumatoid Arthritis
This medicine is used to relieve pain and swelling associated with rheumatoid arthritis, an autoimmune disease that affects the joints, in adult patients. It is also effective in reducing structural damages and improving physical functions in adult patients with moderate to severe rheumatoid arthritis.
-
Juvenile Idiopathic Arthritis
This medicine is used to relieve pain, swelling, structural damage, and developmental defects associated with juvenile idiopathic arthritis, an autoimmune disease that affects the joints in children aged 2 years and above.
-
Psoriatic Arthritis
This medicine is used to relieve pain, swelling, and formation of scales on the skin associated with psoriatic arthritis (an autoimmune disease affects the joints in patients with psoriasis) in adults. It also reduces structural damages and improves physical functions in adults with psoriatic arthritis.
-
Ankylosing Spondylitis
This medicine is used to relieve pain, swelling, and structural damage associated with ankylosing spondylitis, an autoimmune disease affects the vertebral column in adults.
-
Chronic plaque psoriasis
This medicine is used for the treatment of moderate to severe chronic plaque psoriasis where systemic therapy or phototherapy can be used and use of other medicines are inappropriate.
Concerns
Frequently asked questions
-
Onset of action
The amount of time required for this medicine to show its effect is 1-2 weeks.
-
Duration of Effect
The amount of time for which this medicine remains effective in the body is not clinically established.
-
Safe with Alchohol?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
-
Is it habit forming?
No habit-forming tendencies were reported.
-
Usage in pregnancy?
This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
-
Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition
When not to use?
-
Allergy
This medicine is not recommended for use in patients with a known allergy to Benepali 50mg pack of 2 Prefilled pen (Etanercept) ^ or any other inactive ingredients present along with it.
-
Active infections
This medicine is not recommended for use in patients who have an active infection or at risk of sepsis due to the increased risk of worsening of the patient's condition.
Warnings
-
Pregnancy
This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
-
Breast-feeding
This medicine is not recommended for use in breastfeeding women. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition
-
Other medicines
This medicine may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.
-
Serious infection
Use of this medicine may affect the immune system making you susceptible to opportunistic infections from a wide variety of pathogens. It is advised to not use this medicine during an active infection. Use of this medicine should be discontinued after consulting the doctor if a serious infection develops.
-
Hepatitis B virus reactivation
Use of this medicine may increase the risk of reactivation of hepatitis b virus in patients who are chronic carriers. Close clinical monitoring is advised if the patient is identified as a carrier of the virus for several months after the use of this medicine.
-
Neurological reactions
Use of this medicine may cause neurological problems and exacerbate the symptoms of nervous system disorders. This medicine should be used with caution in patients with a preexisting nervous system disorder like multiple sclerosis, optic neuritis, Guillain-Barre syndrome etc.
-
Serious allergic reactions
Use of this medicine may cause serious and life-threatening allergic reactions in some people. Discontinue the use of this medicine immediately if any allergic reactions occur.
-
Malignancies
Use of this medicine may cause malignancy or reactivation of a previously treated malignancy. Hence it should be used with caution and frequent clinical monitoring should be performed especially for children, adolescents, and young adults.
-
Autoimmunity
Use of this medicine may result in the formation of autoantibodies and may cause a lupus-like syndrome. Treatment with this medicine should be discontinued immediately in such cases.
-
Immunization
Use of live vaccines should be avoided while a patient is being treated with this medicine. Special precaution is advised for pediatric patients.
-
Hematological reactions
Use of this medicine may cause blood cell component disorders. Use of this medicine should be stopped if any serious blood cell component abnormality is identified.
-
Heart failure
Use of this medicine has been associated with worsening of congestive heart failure and new onset in some rare cases. This medicine should be used with caution and frequent clinical monitoring for patients who have heart failure.
-
Use in Children
This medicine is not recommended for use in children below 2 years of age for Juvenie idiopathic arthritis and 4 years for plaque psoriasis since the safety and efficacy of use are not clinically established.
Dosage
-
Missed Dose
Administer the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.
-
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.
Interactions
Interaction with Medicines- Corticosteroids severe
- Live attenuated vaccines and related products severe
- Ganciclovir severe
- Adalimumab severe
- Azathioprine severe
-
severe
This medicine should be used with caution in patients with a history of hepatitis B infection since it causes reactivation of the infection. It is recommended to monitor patients with evidence of current or prior hepatitis B infection for signs and symptoms of reactivation. An alternative treatment option should be considered in some cases based on the clinical condition.
-
severe
Use of this medicine may cause serious and life-threatening infections caused by a wide variety of pathogens. Hence, treatment with this medicine should not be initiated in a patient with an active infection. While taking this medicine, any signs and symptoms of an infection like fever, chills, sore throat, diarrhea etc should be reported to the doctor immediately.
-
moderate
This medicine should be used with caution in patients with alcoholic hepatitis since it may worsen the condition. Close monitoring of liver function is required in these patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.
-
moderate
This medicine should be used with caution in patients with congestive heart failure since it may worsen the condition. Close monitoring of cardiac function is required in these patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.Hematologic abnormalities
-
moderate
This medicine should be used with caution in patients with hematologic abnormalities since it may worsen the condition. Report any symptoms such as persistent fever, bruising, bleeding, pallor to the doctor immediately. Close monitoring is required in these patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition. Discontinuation of therapy should be considered in patients with confirmed significant hematologic abnormalities.
-
moderate
This medicine should be used with caution in patients with an active central nervous system disorder as the risk of worsening of the condition is significantly high. Report any unusual symptoms to the doctor on priority. It is recommended to discontinue the use of this medicine if neurological disorders develop during the treatment course.
-
moderate
This medicine should be used with extreme caution in patients who have previously been treated for latent or active tuberculosis due to the increased risk of reactivation of the disease. Anti-tuberculosis therapy should be initiated prior to therapy with this medicine if an active infection is confirmed. Appropriate tests should be conducted for the presence of latent tuberculosis in patients.
-
moderate
This medicine should be used with extreme caution in patients who have Wegener's granulomatosis, an autoimmune disease that affects the blood vessels due to the increased risk of worsening of the patient's condition. The incidence of non-cutaneous malignancies of various types was significantly higher in patients treated with this medicine. An alternative treatment option should be considered in some cases based on the clinical condition.
General Instructions
It is advised to administer this medicine under the supervision of a doctor or a trained healthcare professional. Your dose regimen and frequency of administration is likely to vary based on the condition being treated. Consult your doctor immediately if you develop any signs and symptoms of an infection.
Other details
- Usage does not depend on food timings
- To be taken as instructed by doctor
- Effect on sleep is not established
References
- drugbank - Etanercept [Internet]. Available from: https://go.drugbank.com/drugs/DB00005 [cited 1/28/2021]. 2021
One of the following licensed pharmacy from the nearest location will deliver Benepali 50mg pack of 2 Prefilled pen (Etanercept) ^. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
Related products
-
Josh Dotted 1 Pack 150
Uncategorized -
-
-
Products listed on medicalstore.com.pk are 100% genuine and sourced from licensed pharmacies.
We work hard to bring you unimaginable discounts without compromising on quality.
We uses SSL (standard security technology) to ensure data privacy of all our customers.
Reviews
There are no reviews yet.